New Zealand markets open in 8 hours 37 minutes

Alnylam Pharmaceuticals, Inc. (ALNY)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
233.85+4.46 (+1.94%)
At close: 04:00PM EDT
231.20 -2.65 (-1.13%)
Pre-market: 09:05AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts19192321
Avg. Estimate-1.79-1.7-7.42-4.24
Low estimate-2.33-2.96-9.41-8.03
High estimate-1.250.24-4.830.89
Year ago EPS-1.72-2.16-7.2-7.42
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts18182424
Avg. Estimate292.15M334.61M1.07B1.62B
Low estimate246.65M300M1B1.31B
High estimate327.8M403.35M1.12B2.13B
Year ago sales218.69M258.54M844.29M1.07B
Sales growth (year/est)33.60%29.40%27.30%50.90%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-1.57-1.54-1.84-1.63
Actual EPS-1.72-2.16-2-2.29
Difference-0.15-0.62-0.16-0.66
Surprise %-9.60%-40.30%-8.70%-40.50%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate-1.79-1.7-7.42-4.24
7 days ago-1.78-1.7-7.42-4.1
30 days ago-1.68-1.68-6.83-3.43
60 days ago-1.68-1.66-6.63-3.14
90 days ago-1.6-1.54-6.4-2.94
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/A112
Up last 30 days68511
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2112
Growth estimatesALNYIndustrySector(s)S&P 500
Current qtr.-4.10%N/AN/AN/A
Next qtr.21.30%N/AN/AN/A
Current year-3.10%N/AN/AN/A
Next year42.90%N/AN/AN/A
Next 5 years (per annum)7.86%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A